Resveratrol regulates the expression of LXR-α in human macrophages

Biochemical and Biophysical Research Communications

Volumn 348, Issue 3, 2006, Pages 1047-1054

  Sevov, Marie ^a   Elfineh, Lioudmila ^a   Cavelier, Lucia B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Chromatin immunoprecipitation; Gene regulation; LXR ; Macrophages; Resveratrol; THP 1

Indexed keywords

ABC TRANSPORTER A1; ATP BINDING CASSETTE TRANSPORTER G1; CARRIER PROTEIN; CHOLESTEROL; LIPID; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIVER X RECEPTOR ALPHA; MESSENGER RNA; POLYPHENOL; RESVERATROL; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; LIPID TRANSPORT; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; UPREGULATION;

CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; MACROPHAGES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; STILBENES; UP-REGULATION;

ANIMALIA;

EID: 33747198105     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.155     Document Type: Article

References (63)

1. Renaud S., and de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339 (1992) 1523-1526
2. Tunstall-Pedoe H., Kuulasmaa K., Mahonen M., Tolonen H., and Ruokokoski E. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 353 (1999) 1547-1557
3. Gronbaek M., Deis A., Sorensen T.I.A., Becker U., Schnohr P., and Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. Br. Med. J. 310 (1995) 1165-1169
4. Di Castelnuovo A., Rotondo S., Iacoviello L., Donati M.B., and de Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 105 (2002) 2836-2844
5. Gronbaek M., Becker U., Johansen D., Gottschau A., Schnohr P., Hein H.O., Jensen G., and Sorensen T.I.A. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann. Intern. Med. 133 (2000) 411-419
6. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?. Eur. J. Endocrinol. 138 (1998) 619-620
7. Wang Z.J., Cao K., Hsieh T.C., Huang Y., and Wu J.M. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int. J. Mol. Med. 16 (2005) 533-540
8. Auger C., Teissedre P.-L., Gerain P., Lequeux N., Bornet A., Serisier S., Besancon P., Caporiccio B., Cristol J.-P., and Rouanet J.-M. Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J. Agric. Food Chem. 53 (2005) 2015-2021
9. Fuhrman B., Volkova N., Coleman R., and Aviram M. Grape powder polyphenols attenuate atherosclerosis development in Apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. J. Nutr. 135 (2005) 722-728
10. Vinson J.A., Teufel K., and Wu N. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 156 (2001) 67-72
11. Pal S., Ho N., Santos C., Dubois P., Mamo J., Croft K., and Allister E. Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells. J. Nutr. 133 (2003) 700-706
12. Fremont L., Belguendouz L., and Delpal S. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci. 64 (1999) 2511-2521
13. Wang Z., Huang Y., Zou J., Cao K., Xu Y., and Wu J.M. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int. J. Mol. Med. 9 (2002) 77-79
14. Araim O., Ballantyne J., Waterhouse A.L., and Sumpio B.E. Inhibition of vascular smooth muscle cell proliferation with red wine and red wine polyphenols. J. Vasc. Surg. 35 (2002) 1226-1232
15. Youn H.S., Lee J.Y., Fitzgerald K.A., Young H.A., Akira S., and Hwang D.H. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 175 (2005) 3339-3346
16. Tsai S.-H., Lin-Shiau S.-Y., and Lin J.-K. Suppression of nitric oxide synthase and the down-regulation of the activation of NF[kappa]B in macrophages by resveratrol. Br. J. Pharmacol. 126 (1999) 673-680
17. Perret B., Ruidavets J.B., Vieu C., Jaspard B., Cambou J.P., Terce F., and Collet X. Alcohol consumption is associated with enrichment of high-density lipoprotein particles in polyunsaturated lipids and increased cholesterol esterification rate. Alcohol. Clin. Exp. Res. 26 (2002) 1134-1140
18. Tsang C., Higgins S., Duthie G.G., Duthie S.J., Howie M., Mullen W., Lean M.E., and Crozier A. The influence of moderate red wine consumption on antioxidant status and indices of oxidative stress associated with CHD in healthy volunteers. Br. J. Nutr. 93 (2005) 233-240
19. Avellone G., Di Garbo V., Campisi D., De Simone R., Raneli G., Scaglione R., and Licata G. Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. Eur. J. Clin. Nutr. 60 (2005) 41-47
20. Johansen D., Andersen P.K., Jensen M.K., Schnohr P., and Gronbaek M. Copenhagen city heart study. Nonlinear relation between alcohol intake and high-density lipoprotein cholesterol level: results from the Copenhagen city heart study. Alcohol. Clin. Exp. Res. 27 (2003) 1305-1309
21. A.S. Hansen, P. Marckmann, L.O. Dragsted, I.-L. Finne Nielsen, S.E. Nielsen, M. Gronbak, Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease, 59 (2005) 449-455.
22. Gaziano J.M., Buring J.E., Breslow J.L., Goldhaber S.Z., Rosner B., VanDenburgh M., Willett W., and Hennekens C.H. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N. Engl. J. Med. 329 (1993) 1829-1834
23. Rimm E.B., Williams P., Fosher K., Criqui M., and Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Br. Med. J. 319 (1999) 1523-1528
24. Gaziano J.M., Hennekens C.H., Godfried S.L., Sesso H.D., Glynn R.J., Breslow J.L., and Buring J.E. Type of alcoholic beverage and risk of myocardial infarction. Am. J. Cardiol. 83 (1999) 52-57
25. Araya J., Rodrigo R., Orellana M., and Rivera G. Red wine raises plasma HDL and preserves long-chain polyunsaturated fatty acids in rat kidney and erythrocytes. Br. J. Nutr. 86 (2001) 189-195
26. Auger C., Caporiccio B., Landrault N., Teissedre P.L., Laurent C., Cros G., Besancon P., and Rouanet J.-M. Red wine phenolic compounds reduce plasma lipids and Apolipoprotein B and prevent early aortic atherosclerosis in hypercholesterolemic golden syrian hamsters (Mesocricetus auratus). J. Nutr. 132 (2002) 1207-1213
27. Costet P., Luo Y., Wang N., and Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275 (2000) 28240-28245
28. Venkateswaran A., Laffitte B.A., Joseph S.B., Mak P.A., Wilpitz D.C., Edwards P.A., and Tontonoz P. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRalpha. Proc. Natl. Acad. Sci. USA 97 (2000) 12097-12102
29. Venkateswaran A., Repa J.J., Lobaccaro J.-M.A., Bronson A., Mangelsdorf D.J., and Edwards P.A. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem. 275 (2000) 14700-14707
30. Laffitte B.A., Repa J.J., Joseph S.B., Wilpitz D.C., Kast H.R., Mangelsdorf D.J., and Tontonoz P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA 98 (2001) 507-512
31. Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., and Mangelsdorf D.J. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. USA 96 (1999) 266-271
32. Laffitte B.A., Joseph S.B., Walczak R., Pei L., Wilpitz D.C., Collins J.L., and Tontonoz P. Autoregulation of the zHuman Liver X Receptor alpha Promoter. Mol. Cell. Biol. 21 (2001) 7558-7568
33. Whitney K.D., Watson M.A., Goodwin B., Galardi C.M., Maglich J.M., Wilson J.G., Willson T.M., Collins J.L., and Kliewer S.A. Liver X Receptor (LXR) regulation of the LXRalpha gene in human macrophages. J. Biol. Chem. 276 (2001) 43509-43515
34. Joseph S.B., Castrillo A., Laffitte B.A., Mangelsdorf D.J., and Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9 (2003) 213-219
35. Van Eck M., Zimmermann R., Groot P.H.E., Zechner R., and Van Berkel T.J.C. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 53e-62e
36. Babaev V.R., Fazio S., Gleaves L.A., Carter K.J., Semenkovich C.F., and Linton M.F. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J. Clin. Invest. 103 (1999) 1697-1705
37. de Winther M.P.J., van Dijk K.W., Havekes L.M., and Hofker M.H. Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 290-297
38. Goldberg I. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37 (1996) 693-707
39. Lindqvist P., Ostlund-Lindqvist A., Witztum J., Steinberg D., and Little J. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. J. Biol. Chem. 258 (1983) 9086-9092
40. Goldstein J.L., Ho Y.K., Basu S.K., and Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76 (1979) 333-337
41. Rohrer L., Freeman M., Kodama T., Penman M., and Krieger M. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 343 (1990) 570-572
42. Babaev V.R., Gleaves L.A., Carter K.J., Suzuki H., Kodama T., Fazio S., and Linton M.F. Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2593-2599
43. Schubeler D., MacAlpine D.M., Scalzo D., Wirbelauer C., Kooperberg C., van Leeuwen F., Gottschling D.E., O'Neill L.P., Turner B.M., Delrow J., Bell S.P., and Groudine M. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev. 18 (2004) 1263-1271
44. Kim T.H., Barrera L.O., Zheng M., Qu C., Singer M.A., Richmond T.A., Wu Y., Green R.D., and Ren B. A high-resolution map of active promoters in the human genome. Nature 436 (2005) 876-880
45. Roh T.-Y., Cuddapah S., and Zhao K. Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev. 19 (2005) 542-552
46. Cooper S.J., Trinklein N.D., Anton E.D., Nguyen L., and Myers R.M. Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome. Genome Res. 16 (2006) 1-10
47. Kim T.H., Barrera L.O., Qu C., Van Calcar S., Trinklein N.D., Cooper S.J., Luna R.M., Glass C.K., Rosenfeld M.G., Myers R.M., and Ren B. Direct isolation and identification of promoters in the human genome. Genome Res. 15 (2005) 830-839
48. Dilworth F.J., Fromental-Ramain C., Yamamoto K., and Chambon P. ATP-driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR in vitro. Mol. Cell 6 (2000) 1049-1058
49. Hatzis P., and Talianidis I. Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol. Cell 10 (2002) 1467-1477
50. F. Flamant, K. Gauthier, J. Samarut, Thyroid hormones signaling is getting more complex: STORMs are coming, Mol. Endocrinol. (2006) me.2006-0035.
51. Hartman H.B., Yu J., Alenghat T., Ishizuka T., and Lazar M.A. The histone-binding code of nuclear receptor co-repressors matches the substrate specificity of histone deacetylase 3. EMBO Rep. 6 (2005) 445-451
52. Wagner B.L., Valledor A.F., Shao G., Daige C.L., Bischoff E.D., Petrowski M., Jepsen K., Baek S.H., Heyman R.A., Rosenfeld M.G., Schulman I.G., and Glass C.K. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol. Cell. Biol. 23 (2003) 5780-5789
53. Donati G., Imbriano C., and Mantovani R. Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters. Nucleic Acids Res. 34 (2006) 3116-3127
54. Klinge C.M., Blankenship K.A., Risinger K.E., Bhatnagar S., Noisin E.L., Sumanasekera W.K., Zhao L., Brey D.M., and Keynton R.S. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors {alpha} and {beta} in endothelial cells. J. Biol. Chem. 280 (2005) 7460-7468
55. Rowan B.G., Weigel N.L., and O'Malley B.W. Phosphorylation of steroid receptor coactivator-1. identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J. Biol. Chem. 275 (2000) 4475-4483
56. Huuskonen J., Fielding P.E., and Fielding C.J. Role of p160 coactivator complex in the activation of liver X receptor. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 703-708
57. Wang N., Silver D.L., Costet P., and Tall A.R. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275 (2000) 33053-33058
58. Wang N., Lan D., Chen W., Matsuura F., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA 101 (2004) 9774-9779
59. Gelissen I.C., Harris M., Rye K.-A., Quinn C., Brown A.J., Kockx M., Cartland S., Packianathan M., Kritharides L., and Jessup W. ABCA1 and ABCG1 synergize to mediate cholesterol export to ApoA-I. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 534-540
60. Jayatilake G.S., Jayasuriya H., Lee E.S., Koonchanok N.M., Geahlen R.L., Ashendel C.L., McLaughlin J.L., and Chang C.J. Kinase inhibitors from Polygonum cuspidatum. J. Nat. Prod. 56 (1993) 1805-1810
61. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., and Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273 (1998) 21875-21882
62. Li Q., Tsujita M., and Yokoyama S. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Biochemistry 36 (1997) 12045-12052
63. Kiss R.S., Maric J., and Marcel Y.L. Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux. J. Lipid Res. 46 (2005) 1877-1887